These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15368585)

  • 1. In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins.
    Sun RW; Yu WY; Sun H; Che CM
    Chembiochem; 2004 Sep; 5(9):1293-8. PubMed ID: 15368585
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel gold(I) phosphine compounds inhibit HIV-1 enzymes.
    Fonteh P; Meyer D
    Metallomics; 2009 Sep; 1(5):427-33. PubMed ID: 21305147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of selected plant extracts for in vitro inhibitory activity on HIV-1 reverse transcriptase (HIV-1 RT).
    Mlinaric A; Kreft S; Umek A; Strukelj B
    Pharmazie; 2000 Jan; 55(1):75-7. PubMed ID: 10683878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1.
    Herschhorn A; Hizi A
    J Med Chem; 2008 Sep; 51(18):5702-13. PubMed ID: 18800765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor.
    Sato A; Hammond J; Alexander TN; Graham JP; Binford S; Sugita K; Sugimoto H; Fujiwara T; Patick AK
    Antiviral Res; 2006 Jun; 70(2):66-74. PubMed ID: 16472877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.
    Grohmann D; Corradi V; Elbasyouny M; Baude A; Horenkamp F; Laufer SD; Manetti F; Botta M; Restle T
    Chembiochem; 2008 Apr; 9(6):916-22. PubMed ID: 18318036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
    Oz Gleenberg I; Herschhorn A; Goldgur Y; Hizi A
    Arch Biochem Biophys; 2007 Feb; 458(2):202-12. PubMed ID: 17257575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzyme.
    Cancio R; Silvestri R; Ragno R; Artico M; De Martino G; La Regina G; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4546-54. PubMed ID: 16251294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    O'Meara JA; Jakalian A; LaPlante S; Bonneau PR; Coulombe R; Faucher AM; Guse I; Landry S; Racine J; Simoneau B; Thavonekham B; Yoakim C
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3362-6. PubMed ID: 17451954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The K101P and K103R/V179D mutations in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nonnucleoside reverse transcriptase inhibitors.
    Parkin NT; Gupta S; Chappey C; Petropoulos CJ
    Antimicrob Agents Chemother; 2006 Jan; 50(1):351-4. PubMed ID: 16377709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?
    Camarasa MJ; Velázquez S; San-Félix A; Pérez-Pérez MJ; Gago F
    Antiviral Res; 2006 Sep; 71(2-3):260-7. PubMed ID: 16872687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)methane)gold(III) chloride: An HIV-1 reverse transcriptase and protease inhibitor.
    Fonteh PN; Keter FK; Meyer D; Guzei IA; Darkwa J
    J Inorg Biochem; 2009 Feb; 103(2):190-4. PubMed ID: 19019450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase.
    Bessong PO; Obi CL; Andréola ML; Rojas LB; Pouységu L; Igumbor E; Meyer JJ; Quideau S; Litvak S
    J Ethnopharmacol; 2005 May; 99(1):83-91. PubMed ID: 15848024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa.
    Wang J; Wang HX; Ng TB
    Peptides; 2007 Mar; 28(3):560-5. PubMed ID: 17113195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
    Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
    Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
    Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
    J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
    Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Wang YP; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Eur J Med Chem; 2009 Mar; 44(3):1016-23. PubMed ID: 18692274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.